P E Smith| - JoVE Visualize

Showing results (51-60 of 60) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 60 results.

British Journal of Rheumatology|October 1, 1989

Myositis ossificans non-progressiva--reversible muscle calcification in polymyositisJ H Coakley, P E Smith, M J Jackson, et al.

Annals of Neurology|July 18, 2001

Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 geneR W Taylor, R Singh-Kler, C M Hayes, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1987

Conchotome and needle percutaneous biopsy of skeletal muscleP Dietrichson, J Coakley, P E Smith, et al.

The European Respiratory Journal|April 1, 1991

Domiciliary investigation of sleep-related hypoxaemia in Duchenne muscular dystrophyN Carroll, R J Bain, P E Smith, et al.

Journal of Dairy Science|January 31, 2025

The role of rumen microbiome in the development of methane mitigation strategies for ruminant livestockS M Waters, E Roskam, P E Smith, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|December 8, 2011

Genetic epilepsy with febrile seizures plus: definite and borderline phenotypesR H Thomas, J A Johnston, C L Hammond, et al.

Annals of Surgical Oncology|January 1, 1994

Intrapleural photodynamic therapy: results of a phase I trialH I Pass, T F DeLaney, Z Tochner, et al.

The Journal of Infection|November 29, 2011

Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National GuidelinesT Solomon, B D Michael, P E Smith, et al.

Seizure|June 23, 2017

Epilepsy and Pregnancy: For healthy pregnancies and happy outcomes. Suggestions for service improvements from the Multispecialty UK Epilepsy Mortality GroupJ P Leach, P E Smith, J Craig, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2026

Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC post-progression on first-line osimertinib: ORCHARDJ W Riess, H A Yu, X Le, et al.

Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 60 results.

British Journal of Rheumatology|October 1, 1989

Myositis ossificans non-progressiva--reversible muscle calcification in polymyositisJ H Coakley, P E Smith, M J Jackson, et al.

Annals of Neurology|July 18, 2001

Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 geneR W Taylor, R Singh-Kler, C M Hayes, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1987

Conchotome and needle percutaneous biopsy of skeletal muscleP Dietrichson, J Coakley, P E Smith, et al.

The European Respiratory Journal|April 1, 1991

Domiciliary investigation of sleep-related hypoxaemia in Duchenne muscular dystrophyN Carroll, R J Bain, P E Smith, et al.

Journal of Dairy Science|January 31, 2025

The role of rumen microbiome in the development of methane mitigation strategies for ruminant livestockS M Waters, E Roskam, P E Smith, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|December 8, 2011

Genetic epilepsy with febrile seizures plus: definite and borderline phenotypesR H Thomas, J A Johnston, C L Hammond, et al.

Annals of Surgical Oncology|January 1, 1994

Intrapleural photodynamic therapy: results of a phase I trialH I Pass, T F DeLaney, Z Tochner, et al.

The Journal of Infection|November 29, 2011

Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National GuidelinesT Solomon, B D Michael, P E Smith, et al.

Seizure|June 23, 2017

Epilepsy and Pregnancy: For healthy pregnancies and happy outcomes. Suggestions for service improvements from the Multispecialty UK Epilepsy Mortality GroupJ P Leach, P E Smith, J Craig, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2026

Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC post-progression on first-line osimertinib: ORCHARDJ W Riess, H A Yu, X Le, et al.

Pageof 6